338
Views
30
CrossRef citations to date
0
Altmetric
ORIGINAL INVESTIGATION

The influence of concomitant neuroleptic medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy

, , , , , , , & , MD show all
Pages 162-170 | Received 04 May 2005, Published online: 12 Jul 2009

References

  • Abrams R. Recent clinical studies of ECT. Semin Psychiatry 1972; 4: 3–12
  • Abrams R. A hypothesis to explain divergent findings among studies comparing the efficacy of unilateral and bilateral ECT in depression. Convuls Ther 1986; 2: 253–257
  • Abrams R. Stimulus titration and ECT dosing. J ECT 2002; 18: 3–9
  • Amann BL, Pogarell O, Mergl R, Juckel G, Grunze H, Mulert C, Hegerl U. EEG abnormalities associated with antipsychotics: a comparison of quetiapine, olanzapine, haloperidol and healthy subjects. Hum Psychopharmacol 2003; 18: 641–646
  • Benkert O, Hippius H. Kompendium der Psychiatrsichen Pharmakotherapie. Springer, Heidelberg 2003
  • Coffey CE, Lucke J, Weiner RD, Krystal AD, Aque M. Seizure threshold in electroconvulsive therapy: I. Initial seizure threshold. Biol Psychiatry 1995; 37: 713–720
  • d'Elia G. Unilateral electroconvulsive therapy. Acta Psychiatr Scand Suppl 1970; 215: 1–98
  • d'Elia G, Raotma H. Is unilateral ECT less effective than bilateral ECT?. Br J Psychiatry 1975; 126: 83–89
  • ECT Review Group. Efficacy and safety of electroconvulsive therapy in depressive disorders: A systematic review and meta-analysis. Lancet 2003; 361: 799–808
  • Fink M. Clozapine and electroconvulsive therapy. Arch Gen Psychiatry 1990; 47: 290–291
  • Frey R, Heiden A, Scharfetter J, Schreinzer D, Blasbichler T, Tauscher J, Felleiter P, Kasper S. Inverse relation between stimulus intensity and seizure duration: Implications for ECT procedure. J ECT 2001a; 17: 102–108
  • Frey R, Heiden A, Scharfetter J, Schreinzer D, Blasbichler T, Tauscher J, Felleiter P, Kasper S. Inverse relation between stimulus intensity and seizure duration: Implications for ECT procedure. J ECT 2001b; 17: 102–108
  • Gazdag G, Barna I, Ivanyi Z, Tolna J. The impact of neuroleptic medication on seizure threshold and duration in electroconvulsive therapy. Ideggyogy Sz 2004; 57: 385–390
  • Kales HC, DeQuardo JR, Tandon R. Combined electroconvulsive therapy and clozapine in treatment-resistant schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 1999; 23: 547–556
  • Kupchik M, Spivak B, Mester R, Reznik I, Gonen N, Weizman A, Kotler M. Combined electroconvulsive-clozapine therapy. Clin Neuropharmacol 2000; 23: 14–16
  • Lauritzen L, Odgaard K, Clemmesen L, Lunde M, Ohrstrom J, Black C, Bech P. Relapse prevention by means of paroxetine in ECT-treated patients with major depression: A comparison with imipramine and placebo in medium-term continuation therapy. Acta Psychiatr Scand 1996; 94: 241–251
  • Meltzer HY, Bastani B, Kwon KY, Ramirez LF, Burnett S, Sharpe J. A prospective study of clozapine in treatment-resistant schizophrenic patients. I. Preliminary report. Psychopharmacology (Berlin) (Suppl) 1989; 99: S68–72
  • National Institute of Mental Health. 1976. 028 CGI. Clinical global impressions. In:, W Guy, Bonato, RR, editors., Manual for the EDCEU Assessment Battery, 2nd rev., Chevy Chase, MD: National Institute of Mental Health. p, 12-1–12-6.
  • Nobler MS, Sackeim HA, Solomou M, Luber B, Devanand DP, Prudic J. EEG manifestations during ECT: Effects of electrode placement and stimulus intensity. Biol Psychiatry 1993; 34: 321–330
  • O'Brien PD, Berrios GE. Concurrent psychotropic medication has no negative influence on the outcome of electroconvulsive therapy. Encephale 1993; 19: 347–349
  • Sackeim HA, Devanand DP, Prudic J. Stimulus intensity, seizure threshold, and seizure duration: impact on the efficacy and safety of electroconvulsive therapy. Psychiatr Clin North Am 1991; 14: 803–843
  • Sackeim HA, Prudic J, Devanand DP, Nobler MS, Lisanby SH, Peyser S, Fitzsimons L, Moody BJ, Clark J. A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Arch Gen Psychiatry 2000; 57: 425–434
  • Schafer I, Lambert M, Naber D. Atypical antipsychotics in therapy refractory schizophrenia. Nervenarzt 2004; 75: 79–91
  • Suppes T, Webb A, Carmody T, Gordon E, Gutierrez-Esteinou R, Hudson JI, Pope HG, Jr. Is postictal electrical silence a predictor of response to electroconvulsive therapy?. J Affect Disord 1996; 41: 55–58
  • Suzuki K, Awata S, Matsuoka H. One-year outcome after response to ECT in middle-aged and elderly patients with intractable catatonic schizophrenia. J ECT 2004; 20: 99–106
  • Swartz CM, Abrams R, Rasmussen K, Pavel J, Zorumski CF, Srinivasaraghavan J. Computer automated versus visually determined electroencephalographic and electromyographic seizure duration. Convuls Ther 1994; 10: 165–170
  • Swartz CM, Larson G. Generalization of the effects of unilateral and bilateral ECT. Am J Psychiatry 1986; 143: 1040–1041
  • Tang WK, Ungvari GS. Efficacy of electroconvulsive therapy combined with antipsychotic medication in treatment-resistant schizophrenia: A prospective, open trial. J ECT 2002; 18: 90–94
  • Tang WK, Ungvari GS. Efficacy of electroconvulsive therapy in treatment-resistant schizophrenia: A prospective open trial. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27: 373–379
  • Tharyan, P, Adams, CE. 2002. Electroconvulsive therapy for schizophrenia. Cochrane Database Syst Rev, CD000076.
  • Weiner RD, Coffey CE, Krystal AD. The monitoring and management of electrically induced seizures. Psychiatr Clin North Am 1991; 14: 845–869
  • Weiner RD, Weaver LA, Jr, Sackeim HA. Reporting of technical parameters in ECT publications: Recommendations for authors. Convuls Ther 1988; 4: 88–91
  • World Health Organization. 1992. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical descriptions and diagnostic guidelines. Geneva: World Health Organization.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.